Oncotelic Therapeutics Inc

OTC: OTLC
Share price (12/20/24): $0.03
Market cap (12/20/24): $12.3 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 6 pages Amendment No. 1 to Agreement and Plan of Merger

from 8-K 53 pages Agreement and Plan of Merger by and Among Mateon Therapeutics, Inc. Paris Acquisition Corp., Pointr Data Inc. and Saran Saund, as Securityholder Representative Dated as of August 17, 2019 Agreement and Plan of Merger

from 8-K 42 pages Agreement and Plan of Merger

from 8-K 95 pages Agreement and Plan of Merger by and Among Oxigene, Inc., a Delaware Corporation; Oxigene Merger Sub, Inc., a Delaware Corporation; Vaxgen, Inc., a Delaware Corporation; and James Panek as the Stockholder Representative Dated as of October 14, 2009

from 425 95 pages Agreement and Plan of Merger by and Among Oxigene, Inc., a Delaware Corporation; Oxigene Merger Sub, Inc., a Delaware Corporation; Vaxgen, Inc., a Delaware Corporation; and James Panek as the Stockholder Representative Dated as of October 14, 2009

from SC 13G 1 page Power of Attorney